XAMS
PHIA
Market cap26bUSD
Jun 18, Last price
23.50EUR
1D
1.51%
1Q
2.93%
Jan 2017
-17.32%
IPO
40.26%
Name
Koninklijke Philips NV
Chart & Performance
P/E
—
P/S
1.27
EPS
—
Div Yield, %
3.62%
Shrs. gr., 5y
-0.82%
Rev. gr., 5y
-1.55%
Revenues
18.02b
-0.81%
Net income
-702m
L+50.64%
CFO
1.57b
-30.54%
Dividend
May 12, 20260.85 EUR/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Koninklijke Philips N.V., a prominent global health technology enterprise, conducts its operations across North America and various international markets. The company's business activities are structured into three primary segments: Diagnosis & Treatment, Connected Care, and Personal Health. Within its Diagnosis & Treatment division, Philips provides sophisticated diagnostic imaging technologies, including magnetic resonance imaging (MRI), computed tomography (CT) scanners, X-ray systems, and spectral CT solutions, alongside molecular and hybrid imaging for nuclear medicine. This segment also encompasses integrated systems for interventional procedures, ultrasound (echography) devices vital for diagnosis, treatment planning, and guidance in cardiology, general imaging, obstetrics/gynecology, and point-of-care settings, as well as proprietary software to aid diagnostics and interventions, complemented by comprehensive enterprise diagnostic informatics products and services. The Connected Care segment delivers solutions for acute patient management, emergency medical services, and sleep and respiratory care, extending to electronic medical record and various care management platforms. Meanwhile, the Personal Health division markets consumer products such as electric toothbrushes, brush heads, interdental cleaning, and teeth whitening items. It further offers infant feeding and digital parenting technologies, along with male grooming and beauty appliances. Philips has forged key collaborations, including a strategic alliance with Ibex Medical Analytics Ltd. to jointly promote digital pathology and AI solutions to healthcare providers globally, and a strategic partnership with NICO.LAB. Established in 1891 and headquartered in Amsterdam, the Netherlands, the enterprise rebranded from Koninklijke Philips Electronics N.V. to its current name, Koninklijke Philips N.V., in May 2013.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||